Interested in learning more? The American Porphyria Foundation will share details of the study and connect EPP and XLP patients (Ages 12-75) with a study site for the Mitsubishi Phase 3 clinical trial for MT-7117.
New study site locations at Porphyria Centers have recently been added, including:
Patients can also participate at the following study sites:
If you are interested in learning more, please contact Edrin Williams, Director of Patient Services; he will connect you with a research coordinator.
Phone: 301-312-8741 E-mail: email@example.com